Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in five FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, rheumatoid arthritis, asthma, pain and infectious diseases.
In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.
$394.14 11.59 (3.03)%
Market Cap 41.06B
03/29/17 4:15 PM ET | Minimum 20 minutes delay.
Stock information provided by eSignal.